FDA Approves Higher/Less Frequent Doses of Teva's Copaxone as Generics Hover

Teva Pharmaceutical Industries was granted U.S. FDA approval for a longer-acting version of its Copaxone multiple-sclerosis drug.

Source: PharmaManufacturing.com - January 30, 2014 Category: Pharmaceuticals Source Type: news